1. Home
  2. SEE vs RYTM Comparison

SEE vs RYTM Comparison

Compare SEE & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sealed Air Corporation

SEE

Sealed Air Corporation

HOLD

Current Price

$42.15

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$88.13

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEE
RYTM
Founded
1960
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.2B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
SEE
RYTM
Price
$42.15
$88.13
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$43.50
$131.14
AVG Volume (30 Days)
3.3M
672.7K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.90%
N/A
EPS Growth
89.50
28.34
EPS
3.43
N/A
Revenue
$5,359,800,000.00
N/A
Revenue This Year
$1.93
$55.34
Revenue Next Year
$2.27
$86.06
P/E Ratio
$12.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.15
$58.71
52 Week High
$44.27
$122.20

Technical Indicators

Market Signals
Indicator
SEE
RYTM
Relative Strength Index (RSI) 65.73 48.61
Support Level $41.79 $87.19
Resistance Level $42.21 $92.17
Average True Range (ATR) 0.08 4.80
MACD 0.02 -0.24
Stochastic Oscillator 100.00 23.44

Price Performance

Historical Comparison
SEE
RYTM

About SEE Sealed Air Corporation

Sealed Air Corp is a provider of packaging solutions that integrate sustainable, high-performance materials, automation, equipment, and services. The company designs, manufactures, and delivers packaging solutions that preserve food, protect goods, and automate packaging processes. It delivers its packaging solutions to an array of end markets including fresh proteins, foods, fluids and liquids, medical and life science, e-commerce retail, logistics and omnichannel fulfillment operations, and industrials. It has two reportable segments, Food and Protective. The company generates majority of its revenue from the food segment.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: